Table 2.
Pathological and molecular parameters
| Parameter | Available cases |
Spontaneous VDE |
P value | |||
|---|---|---|---|---|---|---|
| Mean ± SD | Median | Range | ||||
| Histological subtype | 407 | .891 | ||||
| Astrocytoma | 76 | 5.7 ± 6.6 | 3.7 | 0.2–35.8 | ||
| Oligodendroglioma | 246 | 5.8 ± 6.5 | 4.0 | 0.2–42.4 | ||
| Mixed glioma | 85 | 5.7 ± 5.6 | 3.9 | 0.2–24.3 | ||
| 1p19q codeletion | 205 | .008 | ||||
| Yes | 67 | 4.6 ± 5.7 | 2.9 | 0.3–34.1 | ||
| No | 138 | 6.2 ± 6.1 | 4.6 | 0.2–42.4 | ||
| 1p deletion (complete) | 206 | .009 | ||||
| Yes | 64 | 4.6 ± 5.7 | 2.8 | 0.3–34.1 | ||
| No | 142 | 6.1 ± 6.1 | 4.6 | 0.2–42.4 | ||
| 1p deletion (partial) | 206 | .446 | ||||
| Yes | 17 | 6.3 ± 5.5 | 5.6 | 0.9–21.1 | ||
| No | 189 | 5.6 ± 6.1 | 3.9 | 0.2–42.4 | ||
| 19q deletion | 205 | .173 | ||||
| Yes | 94 | 5.6 ± 6.9 | 3.9 | 0.3–42.4 | ||
| No | 111 | 5.8 ± 5.3 | 4.4 | 0.2–24.3 | ||
| Proliferation rates | 195 | .620 | ||||
| <5% | 124 | 5.7 ± 5.2 | 3.9 | 0.2–31.0 | ||
| ≥5% | 71 | 5.2 ± 6.3 | 3.3 | 0.3–34.4 | ||
| EGFR amplification | 193 | .669 | ||||
| Yes | 183 | 6.7 ± 6.3 | 4.8 | 1.0–19.9 | ||
| No | 10 | 5.9 ± 6.5 | 4.2 | 0.3–42.4 | ||
| 10q deletion | 181 | .649 | ||||
| Yes | 153 | 5.8 ± 5.4 | 4.9 | 0.3–22.6 | ||
| No | 28 | 5.6 ± 6.2 | 3.8 | 0.2–42.4 | ||
| p53 overexpression | 144 | .004 | ||||
| Yes | 64 | 7.7 ± 7.8 | 5.1 | 0.3–34.1 | ||
| No | 80 | 4.5 ± 4.5 | 3.4 | 0.4–31.0 | ||
| Internexin alpha expression | 39 | .955 | ||||
| Yes | 21 | 6.2 ± 7.8 | 3.4 | 0.4–31.0 | ||
| No | 18 | 6.3 ± 9.2 | 3.4 | 0.5–33.8 | ||
| IDH1 expression | 32 | .245 | ||||
| Yes | 25 | 7.3 ± 8.8 | 3.8 | 0.4–24.7 | ||
| No | 7 | 2.9 ± 1.3 | 2.9 | 1.0–5.0 | ||